pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist
Sep 27, 2016
|
pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference
Sep 22, 2016
|
pSivida Reports Inducement Awards to New President and Chief Executive Officer
Sep 20, 2016
|
pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO
Sep 15, 2016
|
pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results
Sep 12, 2016
|
pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Sep 01, 2016
|
pSivida Announces 13 New Patents Issued or Allowed
Aug 29, 2016
|
Topline Results from First Phase 3 Trial of pSivida's Medidur™ Presented at ASRS Annual Meeting
Aug 15, 2016
|
Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
Aug 09, 2016
|
pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer
Aug 03, 2016
|
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Aug 01, 2016
|
pSivida's Medidur™ Maintains Same High Statistical Significance in Primary Endpoint through 12 Months in First Phase 3 Trial (p Less Than 0.00000001)
Jul 27, 2016
|
Data Shows pSivida's Tethadur™ Provides Prolonged, Sustained Release of Avastin® With High Drug Efficacy
Jul 20, 2016
|
pSivida Corp. Announces Plan to Consolidate all Research and Development in Current U.S. Facility
Jul 15, 2016
|
Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve
Jul 14, 2016
|
pSivida Announces Poster and Oral Presentation on Controlled Release of Avastin® from Tethadur™ Biodegradable Matrix at the 2016 Controlled Release Society Annual Meeting
Jul 08, 2016
|
pSivida Announces Successful Completion of Two Preclinical Studies of Durasert™ Sustained-Release Insert Delivering Repurposed Cancer Drug to Treat Wet AMD
Jul 05, 2016
|
pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results
May 05, 2016
|
pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics
May 04, 2016
|
pSivida's Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe
May 02, 2016
|